Latest News and Press Releases
Want to stay updated on the latest news?
-
Oslo, December 22, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into an agreement with Chemviron Carbon Ltd. (Chemviron)...
-
Oslo, November 20, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a preliminary long-term agreement with G....
-
Oslo, 10. november 2017 - Navamedic ASA (OSE: NAVA), rapporterte driftsinntekter på NOK 44,9 millioner i tredje kvartal 2017, ned fra NOK 65,2 millioner i samme periode i fjor, etter det planlagte...
-
Oslo, November 10, 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 44.9 million in the third quarter of 2017, down from NOK 65.2 million in the same period in 2016, following the planned...
-
Navamedic ASA invites you to a presentation of the third quarter 2017 figures. The presentation takes place at Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Friday 10 November. The...
-
Navamedic ASA invites you to follow an online presentation of the third quarter2017 figures.The presentation will be webcasted at www.navamedic.com - investor relations -presentations - webcast on...
-
Kathryn Baker, Chairman of the Board in Navamedic ASA has of 24 August 2017 acquired 3400 shares in Navamedic ASA. The shares are acquired through her company Lakeside AS at an average price...
-
Oslo, August 21, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a long term agreement with bene-Arznemittel GmbH...
-
Oslo, 28. juli 2017 - Navamedic ASA (OSE: NAVA), rapporterte driftsinntekter på NOK 89,7 millioner i andre kvartal 2017 (NOK 66,7 millioner i Q2 2016), tilsvarende en vekst på 34,4%, hovedsakelig som...
-
Oslo, 28 July 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 89.7 million in the second quarter of 2017 (NOK 66.7 million in Q2 2016), representing a growth of 34.4%, following the...